Ian Holyer

1.5k total citations · 1 hit paper
20 papers, 788 citations indexed

About

Ian Holyer is a scholar working on Immunology, Molecular Biology and Computer Networks and Communications. According to data from OpenAlex, Ian Holyer has authored 20 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 4 papers in Computer Networks and Communications. Recurrent topics in Ian Holyer's work include Galectins and Cancer Biology (8 papers), Glycosylation and Glycoproteins Research (3 papers) and Signaling Pathways in Disease (3 papers). Ian Holyer is often cited by papers focused on Galectins and Cancer Biology (8 papers), Glycosylation and Glycoproteins Research (3 papers) and Signaling Pathways in Disease (3 papers). Ian Holyer collaborates with scholars based in United Kingdom, Sweden and Netherlands. Ian Holyer's co-authors include E. J. Cockayne, James A. Roper, Bita Shadgar, Hakon Leffler, Fredrik R. Zetterberg, Alison C. MacKinnon, Robert J. Slack, Anders N. Pedersen, Carl Diehl and A. Khabut and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Ian Holyer

18 papers receiving 717 citations

Hit Papers

The NP-Completeness of Edge-Coloring 1981 2026 1996 2011 1981 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Holyer United Kingdom 5 561 217 205 194 70 20 788
Maw‐Shang Chang Taiwan 15 377 0.7× 59 0.3× 64 0.3× 154 0.8× 46 0.7× 54 524
Celina M.H. de Figueiredo Brazil 14 589 1.0× 201 0.9× 146 0.7× 102 0.5× 93 1.3× 134 663
Stéphan Thomassé France 16 877 1.6× 341 1.6× 161 0.8× 177 0.9× 144 2.1× 94 990
Jan Arne Telle Norway 16 720 1.3× 131 0.6× 71 0.3× 343 1.8× 82 1.2× 69 864
Peter Damaschke Sweden 15 304 0.5× 51 0.2× 47 0.2× 170 0.9× 28 0.4× 64 554
Leizhen Cai Hong Kong 12 474 0.8× 98 0.5× 47 0.2× 170 0.9× 55 0.8× 30 535
Marek Kubale Poland 14 302 0.5× 102 0.5× 113 0.6× 251 1.3× 30 0.4× 54 630
Frances Rosamond Australia 16 698 1.2× 65 0.3× 61 0.3× 258 1.3× 37 0.5× 64 878
J Bermond France 12 348 0.6× 131 0.6× 328 1.6× 363 1.9× 171 2.4× 22 690
Stefan Kratsch Germany 15 553 1.0× 84 0.4× 54 0.3× 188 1.0× 15 0.2× 56 672

Countries citing papers authored by Ian Holyer

Since Specialization
Citations

This map shows the geographic impact of Ian Holyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Holyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Holyer more than expected).

Fields of papers citing papers by Ian Holyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Holyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Holyer. The network helps show where Ian Holyer may publish in the future.

Co-authorship network of co-authors of Ian Holyer

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Holyer. A scholar is included among the top collaborators of Ian Holyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Holyer. Ian Holyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holyer, Ian, Duncan C. Humphries, James A. Roper, et al.. (2025). Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of Cancer. Pharmacology. 110(4). 207–220. 1 indexed citations
2.
MacKinnon, Alison C., Duncan C. Humphries, James A. Roper, et al.. (2024). Effect of GB1107, a novel galectin-3 inhibitor on pro-fibrotic signalling in the liver. European Journal of Pharmacology. 985. 177077–177077. 4 indexed citations
3.
Aslanis, Vassilios, Robert J. Slack, Lise Gravelle, et al.. (2024). Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1). Cancer Chemotherapy and Pharmacology. 94(5). 707–720. 1 indexed citations
4.
Comeglio, Paolo, Giulia Guarnieri, Sandra Filippi, et al.. (2024). The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis. Frontiers in Pharmacology. 15. 1430109–1430109. 4 indexed citations
5.
Peterson, Kristoffer, Ulf J. Nilsson, Lise Gravelle, et al.. (2024). Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of Cancer. Journal of Medicinal Chemistry. 67(24). 21905–21915. 1 indexed citations
6.
Zetterberg, Fredrik R., Kristoffer Peterson, Ulf J. Nilsson, et al.. (2024). Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer. Journal of Medicinal Chemistry. 67(11). 9374–9388. 14 indexed citations
7.
Holyer, Ian, Duncan C. Humphries, James A. Roper, et al.. (2024). Galectin-1 Induces the Production of Immune-Suppressive Cytokines in Human and Mouse T Cells. International Journal of Molecular Sciences. 25(22). 11948–11948. 2 indexed citations
9.
Holyer, Ian, et al.. (2017). Towards Secure SPARQL Queries in Semantic Web Applications Using PHP. Bristol Research (University of Bristol). 51. 276–277. 2 indexed citations
10.
Shadgar, Bita & Ian Holyer. (2004). Adapting databases and WebDAV protocol. Bristol Research (University of Bristol). 612–620. 1 indexed citations
11.
Shadgar, Bita & Ian Holyer. (2003). An Application for WebDAV-based Authoring of Databases - WebDAD. Bristol Research (University of Bristol). 266–269. 1 indexed citations
12.
Shadgar, Bita & Ian Holyer. (2002). WebDAD: A WebDAV implementation for authoring databases. Bristol Research (University of Bristol). 827–828. 2 indexed citations
13.
Shadgar, Bita & Ian Holyer. (2002). Proceedings of the IADIS International Conference WWW/Internet 2002, ICWI 2002, Lisbon, Portugal, 13-15 November, 2002.
14.
Holyer, Ian. (2000). A Recovery Mechanism for Shells. The Computer Journal. 43(3). 168–176.
15.
Holyer, Ian, et al.. (1998). Implementation of Functional Languages, 9th International Workshop, IFL'97, St. Andrews, Scotland, UK, September 1997, Selected Papers, LNCS 1467. Springer US. 1 indexed citations
16.
Holyer, Ian, et al.. (1998). Distribution in a Demand Driven Style. Bristol Research (University of Bristol). 29–41. 1 indexed citations
17.
Holyer, Ian. (1991). Functional programming with Miranda. Explore Bristol Research. 9 indexed citations
18.
Holyer, Ian. (1981). The NP-Completeness of Some Edge-Partition Problems. SIAM Journal on Computing. 10(4). 713–717. 123 indexed citations
19.
Holyer, Ian. (1981). The NP-Completeness of Edge-Coloring. SIAM Journal on Computing. 10(4). 718–720. 614 indexed citations breakdown →
20.
Holyer, Ian & E. J. Cockayne. (1979). On the sum of cardinalities of extremum maximal independent sets. Discrete Mathematics. 26(3). 243–246. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026